News

Thanks to its expertise in gene therapy vectors for correcting blood stem cells, Genethon is involved in two new clinical trials targeting cells: X-linked chronic granulomatous disease (also called CGD) and Fanconi anemia. X-linked chronic granulomatous disease (CGD), a rare immune system disease, is triggered by a mutation of the CYBB gene which reduces the activity of … [Read more]

Given the increasing success of the “1,000 chercheurs” project, interventions by researchers from the Biotherapies Institute are being deployed overseas. This week, students in year 10 and 12 from six different classes of the Lycée Français of the Mission Laïque Française in Agadir (Marocco) benefited the expertise of Jérôme Nicolas from Genethon by video-conferencing. On the menu? A … [Read more]

Myology 2016, the international congress of myology organized by AFM-Téléthon has ended last week. The researchers who have taken part to the event share their feelings on what was said during the week. “Myology 2016 emphasised on the advances in the field of biotherapies. Impressive preliminary results of trials for gene and cell therapies were presented” … [Read more]

Summary of the fifth and last day of Myology 2016 Watch the testimonies of Xavier Nissan (I-stem), Karl Rouger (INRA, ENV) and Justine Marsolier (Genethon).

A video summary of the fourth day at Myology 2016 Discover the testimonies of Odile Boespflug-Tanguy (AFM-Téléthon), Hawa Dramé (Fitima Fondation), Jon Andoni Urtizberea (AP-HP), and Marina Roussel (AFM-Téléthon).

Guillaume Bassez (Henri Mondor university hospital) talks about the results of his researches.

Bernard Jasmin (University of Ottawa) discusses the factors enabling the modification of myotonic dystrophy.

Caroline Le Guiner (Biotherapies Institute for Rare Diseases) discusses the development of products for gene therapy in Duchenne muscular dystrophy.